The Future of Microbiome Therapeutics

Area of Science:

• Microbiology
• Biotechnology
• Medical Science

Background:

• The human microbiome significantly impacts host biology and is a target for health interventions.
• Current microbiome products often lack sufficient efficacy.
• Technological advancements are enabling new therapeutic approaches.

Purpose of the Study:

• To review state-of-the-art technologies for microbiome therapeutics in late-stage development.
• To examine the advantages and limitations of emerging microbiome-based treatments.
• To provide insight into the future of microbiome therapeutics.

Main Methods:

• Narrative review of current literature and technological advancements.
• Analysis of various microbiome therapeutic modalities.
• Examination of technologies including fecal-derived products, live biotherapeutics, phage therapy, and synthetic biology.

Main Results:

• Several novel technologies are in late-stage development for microbiome therapeutics.
• Each technology presents unique advantages and limitations.
• The reviewed technologies span a range of approaches to modulate the microbiome.

Conclusions:

• Emerging technologies offer significant potential to overcome the efficacy issues of current microbiome products.
• The future of microbiome therapeutics involves diverse strategies, including live biotherapeutics, phage therapy, and synthetic biology.
• Continued technological innovation is crucial for advancing microbiome-based medicine.